OpenURL Connection Search

Select item for more details and to access through your institution.

Applicability of radiomics in interstitial lung disease associated with systemic sclerosis: proof of concept.
Published in:
European Radiology, 2021, v. 31, n. 4, p. 1987, doi. 10.1007/s00330-020-07293-8
By:
- Martini, K.;
- Baessler, B.;
- Bogowicz, M.;
- Blüthgen, C.;
- Mannil, M.;
- Tanadini-Lang, S.;
- Schniering, J.;
- Maurer, B.;
- Frauenfelder, T.
Publication type:
Article
FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients.
Published in:
EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-00669-3
By:
- Pavic, M.;
- Bogowicz, M.;
- Kraft, J.;
- Vuong, D.;
- Mayinger, M.;
- Kroeze, S. G. C.;
- Friess, M.;
- Frauenfelder, T.;
- Andratschke, N.;
- Huellner, M.;
- Weder, W.;
- Guckenberger, M.;
- Tanadini-Lang, S.;
- Opitz, I.
Publication type:
Article
Perfusion CT radiomics as potential prognostic biomarker in head and neck squamous cell carcinoma.
Published in:
Acta Oncologica, 2019, v. 58, n. 10, p. 1514, doi. 10.1080/0284186X.2019.1629013
By:
- Bogowicz, M.;
- Tanadini-Lang, S.;
- Veit-Haibach, P.;
- Pruschy, M.;
- Bender, S.;
- Sharma, A.;
- Hüllner, M.;
- Studer, G.;
- Stieb, S.;
- Hemmatazad, H.;
- Glatz, S.;
- Guckenberger, M.;
- Riesterer, O.
Publication type:
Article
PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.977822
By:
- Gabryś, H. S.;
- Basler, L.;
- Burgermeister, S.;
- Hogan, S.;
- Ahmadsei, M.;
- Pavic, M.;
- Bogowicz, M.;
- Vuong, D.;
- Tanadini-Lang, S.;
- Förster, R.;
- Kudura, K.;
- Huellner, M.;
- Dummer, R.;
- Levesque, M. P.;
- Guckenberger, M.
Publication type:
Article

Found: 4

Applicability of radiomics in interstitial lung disease associated with systemic sclerosis: proof of concept.

FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients.

Perfusion CT radiomics as potential prognostic biomarker in head and neck squamous cell carcinoma.

PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors.